- Page 1 and 2: FUNCTION ORIENTED SYNTHESIS OF BIOA
- Page 3 and 4: The fifth chapter describes synthet
- Page 5 and 6: iological data and “click” chem
- Page 7 and 8: 2.6 Synthesis of a Benzophenone Pho
- Page 9 and 10: List of Tables Table 1.1 The proper
- Page 11 and 12: Figure 2.12 CLogP values of 2.18 an
- Page 13 and 14: Figure 2.41 1 H and 13 C NMR spectr
- Page 15 and 16: Figure 3.28 1 H and 13 C NMR spectr
- Page 17 and 18: Figure 4.6 AR competitor in vitro a
- Page 19 and 20: Figure 5.13 1 H and 13 C NMR spectr
- Page 21 and 22: Scheme 3.5 Synthesis of (R)-niphate
- Page 23 and 24: List of Symbols and Abbreviations
- Page 25 and 26: Lys - lysine m - multiplet M - mola
- Page 27 and 28: Acknowledgements What a trip. First
- Page 29 and 30: Chapter 1: Marine Natural Products
- Page 31 and 32: Table 1.1 The properties of natural
- Page 33 and 34: deprotonates the secondary alcohol
- Page 35 and 36: Figure 1.4 Marine natural product i
- Page 37 and 38: sceptrin 28 (1.20), and (-)-agelife
- Page 39 and 40: polyketide (+)-spongistatin 1 (1.27
- Page 41 and 42: allowing for construction of simpli
- Page 43 and 44: potency, and the synthetic efforts
- Page 45: 4,5-P2, or PIP2). This generates an
- Page 49 and 50: 2.3 Synthesis of SHIP1 Activators U
- Page 51 and 52: intramolecular attack by a nucleoph
- Page 53 and 54: Scheme 2.4 Elimination side product
- Page 55 and 56: As this issue of water solubility i
- Page 57 and 58: Scheme 2.5 Inspiration for biomimet
- Page 59 and 60: Scheme 2.7 Synthesis of amine analo
- Page 61 and 62: Figure 2.13 ORTEP diagram of Mosher
- Page 63 and 64: Reductive amination of oxime 2.41 g
- Page 65 and 66: While primary amines 2.20 and 2.42
- Page 67 and 68: interacts with SHIP1 and if there i
- Page 69 and 70: Figure 2.18 STDD NMR sample prepara
- Page 71 and 72: STDD effects are observed for proto
- Page 73 and 74: Figure 2.22 Commonly used tags. The
- Page 75 and 76: enzophenone fragment can come from
- Page 77 and 78: with thionyl chloride gave acid chl
- Page 79 and 80: These two regioisomers could not be
- Page 81 and 82: This sample was stirred at room tem
- Page 83 and 84: minor �-amine epimers 2.34/2.43 s
- Page 85 and 86: 2.8 Conclusion The activation of SH
- Page 87 and 88: mouse model. The compounds were eff
- Page 89 and 90: otations were measured with a JASCO
- Page 91 and 92: Preparation of 2.3/2.14: To a solut
- Page 93 and 94: Figure 2.28 1 H and 13 C NMR spectr
- Page 95 and 96: Preparation of (±)-2.26: To polyen
- Page 97 and 98:
Preparation of 2.30: To epoxide 2.2
- Page 99 and 100:
Preparation of 2.31: Alcohol 2.30 (
- Page 101 and 102:
Figure 2.31 1 H and 13 C NMR spectr
- Page 103 and 104:
Figure 2.32 1 H and 13 C NMR spectr
- Page 105 and 106:
Figure 2.33 1 H and 13 C NMR spectr
- Page 107 and 108:
Figure 2.34 1 H and 13 C NMR spectr
- Page 109 and 110:
Compound 2.20: 1 H NMR (600 MHz, CD
- Page 111 and 112:
Figure 2.36 1 H and 13 C NMR spectr
- Page 113 and 114:
Preparation of 2.40: To 2.19 (20 mg
- Page 115 and 116:
Preparation of 2.44: To 2.40 (10.3
- Page 117 and 118:
Preparation of 2.45: To 2.44 (8.0 m
- Page 119 and 120:
Preparation of 2.47: To sodium hydr
- Page 121 and 122:
Preparation of 2.61: To acid chlori
- Page 123 and 124:
Preparation of 2.53: To 2.61 (754 m
- Page 125 and 126:
Figure 2.42 NOESY spectrum of 2.53
- Page 127 and 128:
Dry Transfer system (Life Technolog
- Page 129 and 130:
Chapter 3: Glycerol Ethers from the
- Page 131 and 132:
Figure 3.2 Examples of antiandrogen
- Page 133 and 134:
Figure 3.4 Small molecule antagonis
- Page 135 and 136:
the benzyl protected glycerol ether
- Page 137 and 138:
The synthesis of (R)-niphatenone B
- Page 139 and 140:
and B (3.37) were isolated by Matsu
- Page 141 and 142:
Scheme 3.8 Synthesis of a short cha
- Page 143 and 144:
(3.31). This was accomplished by op
- Page 145 and 146:
Acetonide 3.30 was hydrogenated in
- Page 147 and 148:
of an active probe is the quinoline
- Page 149 and 150:
conjugation is disrupted by the nuc
- Page 151 and 152:
Figure 3.11 AR transcriptional acti
- Page 153 and 154:
concentration of either (S) or (R)
- Page 155 and 156:
Each natural product contains one s
- Page 157 and 158:
Preparation of 3.16: Tetrahydrofura
- Page 159 and 160:
Preparation of 3.17: To compound 3.
- Page 161 and 162:
Preparation of 3.18: To alcohol 3.1
- Page 163 and 164:
Preparation of 3.20: Phosphorane 3.
- Page 165 and 166:
Figure 3.17 1 H and 13 C NMR spectr
- Page 167 and 168:
Figure 3.18 1 H and 13 C NMR spectr
- Page 169 and 170:
Preparation of 3.27: NaH (330 mg, 8
- Page 171 and 172:
Preparation of 3.28: To compound 3.
- Page 173 and 174:
Preparation of 3.29: To Dess-Martin
- Page 175 and 176:
Preparation of 3.30: To phosphonate
- Page 177 and 178:
Preparation of 3.31: To acetonide 3
- Page 179 and 180:
Preparation of 3.35: Procedures ide
- Page 181 and 182:
Preparation of 3.34: To bromohydrin
- Page 183 and 184:
Preparation of 3.25: To bromide 3.3
- Page 185 and 186:
Preparation of 3.62: To acetonide 3
- Page 187 and 188:
Preparation of 3.63: To acetonide 3
- Page 189 and 190:
Preparation of 3.41: To ketone 3.40
- Page 191 and 192:
Preparation of 3.42: To phosphonate
- Page 193 and 194:
Preparation of 3.43: To acetonide 3
- Page 195 and 196:
Preparation of 3.45: To phosphonate
- Page 197 and 198:
Preparation of 3.46: To acetonide 3
- Page 199 and 200:
Preparation of 3.48: Sodium hydride
- Page 201 and 202:
Preparation of 3.49: To compound 3.
- Page 203 and 204:
Preparation of 3.50: To Dess-Martin
- Page 205 and 206:
Figure 3.36 1 H and 13 C NMR spectr
- Page 207 and 208:
Figure 3.37 1 H and 13 C NMR spectr
- Page 209 and 210:
Figure 3.38 1 H and 13 C NMR spectr
- Page 211 and 212:
Figure 3.39 1 H and 13 C NMR spectr
- Page 213 and 214:
Preparation of 3.57: To bromine 3.2
- Page 215 and 216:
Preparation of 3.58:� To 3.57 (2.
- Page 217 and 218:
Preparation of 3.59:� To alcohol
- Page 219 and 220:
Preparation of 3.60: To phosphonate
- Page 221 and 222:
Preparation of 3.61: To acetonide 3
- Page 223 and 224:
Preparation of 3.67: To epoxide 3.5
- Page 225 and 226:
Preparation of 3.77: To phosphonate
- Page 227 and 228:
Preparation of 3.78: To 3.77 (20.0
- Page 229 and 230:
AR Transcriptional Activity Assay:
- Page 231 and 232:
Chapter 4: Synthetic Efforts Toward
- Page 233 and 234:
Scheme 4.1 Semisynthesis of 4.1 ana
- Page 235 and 236:
This synthetic route was devised wi
- Page 237 and 238:
Scheme 4.5 Synthesis of regioisomer
- Page 239 and 240:
Figure 4.4 Favored and disfavored r
- Page 241 and 242:
An alternative strategy using 3-fur
- Page 243 and 244:
Scheme 4.10 Mono-thiolated analogue
- Page 245 and 246:
4.4 Biological Results The semisynt
- Page 247 and 248:
Table 4.1 EC50 values for tested co
- Page 249 and 250:
The focus of this chapter is dedica
- Page 251 and 252:
Preparation of 4.16: To a solution
- Page 253 and 254:
Preparation of 4.18: To phosphonate
- Page 255 and 256:
Preparation of 4.19: To 4.18 (333 m
- Page 257 and 258:
Preparation of 4.20: To (-)-DIPT (0
- Page 259 and 260:
Preparation of 4.21: To alcohol 4.2
- Page 261 and 262:
Preparation of 4.22: To bromide 4.1
- Page 263 and 264:
Preparation of 4.23: To sulfone 4.2
- Page 265 and 266:
Preparation of 4.24: To epoxide 4.2
- Page 267 and 268:
Preparation of 4.40: To furan 4.12
- Page 269 and 270:
Preparation of 4.41: To alcohol 4.4
- Page 271 and 272:
Figure 4.16 1 H and 13 C NMR spectr
- Page 273 and 274:
Figure 4.17 1 H and 13 C NMR spectr
- Page 275 and 276:
Figure 4.18 1 H and 13 C NMR spectr
- Page 277 and 278:
Chapter 5: Synthetic Efforts Toward
- Page 279 and 280:
Shortly afterwards, additional pept
- Page 281 and 282:
the nM range in a cathepsin K enzym
- Page 283 and 284:
Scheme 5.2 Synthesis toward lichost
- Page 285 and 286:
primary alcohol and oxidizing it ba
- Page 287 and 288:
was attempted in order to shorten f
- Page 289 and 290:
Scheme 5.6 Alternative route to lic
- Page 291 and 292:
ligand complex was analyzed by a be
- Page 293 and 294:
Preparation of 5.12: To Fmoc-L-vali
- Page 295 and 296:
Preparation of 5.13: To 5.12 (7.0 g
- Page 297 and 298:
Preparation of 5.15: To O-benzyl-Bo
- Page 299 and 300:
Preparation of 5.16: To 5.15 (232.5
- Page 301 and 302:
Preparation of 5.18: Mono Boc prote
- Page 303 and 304:
Figure 5.9 1 H and 13 C NMR spectra
- Page 305 and 306:
127.5, 127.4, 72.2, 70.6, 63.1, 57.
- Page 307 and 308:
Preparation of 5.24: To 5.15 (356.5
- Page 309 and 310:
Preparation of 5.29: To 5.18 (45.7
- Page 311 and 312:
Preparation of 5.30: To 5.29 (42.8
- Page 313 and 314:
Preparation of 5.32: To Fmoc-L-seri
- Page 315 and 316:
Preparation of 5.33: 5.32 (591.3 mg
- Page 317 and 318:
Preparation of 5.35: To the Fmoc pr
- Page 319 and 320:
Preparation of 5.36: Compound 5.35
- Page 321 and 322:
Preparation of 5.37: To 5.36 (13.7
- Page 323 and 324:
Preparation of 5.38: To 5.18 (100 m
- Page 325 and 326:
Preparation of 5.39: To Boc protect
- Page 327 and 328:
Preparation of 5.40: To 5.18 (300 m
- Page 329 and 330:
Chapter 6: Conclusion 6.1 Biologica
- Page 331 and 332:
either niphatenone A (3.8) and/or B
- Page 333 and 334:
Scheme 6.2 Lithiation strategy to c
- Page 335 and 336:
Scheme 6.4 Alternative synthesis of
- Page 337 and 338:
References (1) McGovern, P. E.; Mir
- Page 339 and 340:
(31) Seiple, I. B.; Su, S.; Young,
- Page 341 and 342:
(55) Woodward, R.; Bloch, K. J. Am.
- Page 343 and 344:
(86) Parra-Delgado, H.; Compadre, C
- Page 345 and 346:
(112) Bi, X.; Schmitz, A.; Hayallah
- Page 347 and 348:
(140) Sadar, M. D.; Williams, D. E.
- Page 349 and 350:
(167) Zoretic, P.; Wang, M.; Zhang,
- Page 351 and 352:
(199) Mohamed, M. M.; Sloane, B. F.
- Page 353 and 354:
(224) Shimokawa, J.; Ishiwata, T.;
- Page 355 and 356:
Crystal Data: Empirical Formula C23
- Page 357 and 358:
Structure Solution and Refinement:
- Page 359 and 360:
Crystal Data: Empirical Formula C33
- Page 361 and 362:
Structure Solution and Refinement:
- Page 363 and 364:
non-hydrogen atoms were refined ani
- Page 365:
Structure Solution and Refinement: